<< BACK TO NEWS SECTION

AirLogix Selected by Humana to Provide Specialized Respiratory Disease Management Services

(Dallas, TX - July 21, 2005) AirLogix, the most experienced and trusted leader in respiratory disease management today announced an agreement with Kentucky-based Humana, Inc. (NYSE: HUM) to offer comprehensive respiratory disease management services to Humana members.

Under the agreement, AirLogix will provide specialized asthma care services for Humana commercial members. The program began February 1 under a letter of agreement and will include care for the plan's pediatric and adult populations.

AirLogix will use their award-winning educational materials, in-home support and telephonic interaction to empower Humana’s health plan members in self-care. This agreement reflects a continuing move by health plans to outsource effective, specialized respiratory disease management solutions.

"We are excited to create and develop disease management programs with one of the nation’s most prominent health benefit companies," said Susan B. Riley, CEO of AirLogix. "Our expert respiratory disease intervention and care capabilities will provide Humana with high quality, cost-effective solutions to support their asthma and COPD populations. Humana is committed to offering innovative and effective disease management programs to their members, and we support that commitment with the exceptional care and compassion that we have built our reputation on.”

AirLogix implements its services through proprietary advanced system technology called AirWorx, for member identification and stratification, enrollment, predictive modeling, risk assessment, data collection and comprehensive administrative and outcomes reporting services. As part of the agreement, AirLogix will provide dedicated system infrastructure, care management and operational resources to Humana.

About Humana

Humana Inc., headquartered in Louisville, Ky., is one of the nation's largest publicly traded health benefits companies, with approximately 7 million medical members. Humana offers a diversified portfolio of health insurance products and related services - through traditional and consumer-choice plans - to employer groups, government-sponsored plans, and individuals.

Over its 44-year history, Humana has consistently seized opportunities to meet changing customer needs. Today, the company is a leader in consumer engagement, providing guidance that leads to lower costs and a better health plan experience throughout its diversified customer portfolio. More information regarding Humana is available to investors via the Investor Relations page of the company's web site at www.humana.com, including copies of:

· Annual report to stockholders;

· Securities and Exchange Commission filings;

· Most recent investor conference presentation;

· Quarterly earnings news releases;

· Replay of most recent earnings release conference call;

· Calendar of events (includes upcoming earnings conference call dates, times, and access number, as well as planned interaction with institutional investors);

· Corporate Governance Information.

About AirLogix

AirLogix is the most experienced and trusted leader in chronic respiratory management. Through compassion and dedication, the AirLogix team has delivered the most effective, patient-centric Asthma and COPD programs to over 500,000 members. Through their specialization in respiratory management, AirLogix uses self-care therapies, in-home interaction and powerful informatics processes to deliver the most effective clinical results, higher patient-provider satisfaction and greater cost reductions in respiratory management. For more information, please visit www.AirLogix.com.

Except for historical information contained herein, matters discussed in this news release are forward-looking statements that involve risks and uncertainties. They include but are not limited to those relating to the timely implementation of programs, the impact of competitive product introductions, acceptance and pricing, and, in the case of Humana, those risks detailed in Humana’s filings with the Securities and Exchange Commission (SEC). Actual results may differ materially from any forward-looking statements due to these risks and uncertainties.

Contact: Kate Leach (214) 576-2065

<< BACK TO NEWS SECTION